On Demand: BTOG Webinar – ESMO 2023 Update

posted in: completed | 0

Originally live on Wednesday 8th November 2023, 18:00-19:10 Chaired by Professor Sanjay Popat, this webinar covered clinically impactful thoracic oncology highlights of ESMO 2023 held in Madrid. To view this event on demand, please register at www.btogwebinars.org  If you have previously … Read More

On Demand: WCLC 2023 Update BTOG Webinar

posted in: completed | 0

Originally live on Monday 25th September 2023, 18:00-19:30 Chaired by Professor Sanjay Popat, this webinar covered clinically impactful thoracic oncology highlights of WCLC 2023 held 9th to 12th September 2023 in Singapore. To view this event on demand, please register … Read More

New NICE Result: Lorlatinib

posted in: NICE News | 0

BTOG is disappointed that lorlatinib has not been recommended, within its marketing authorisation, for treating anaplastic lymphoma kinase (ALK)-positive advanced non-small cell lung cancer (NSCLC) in adults who have not had an ALK inhibitor (1st line, CROWN indication). This recommendation … Read More

Trainee Enews October 2023

posted in: Trainee News | 0

Welcome to the inaugural BTOG trainee newsletter, where we aim to provide you with updates relevant to trainees working in the thoracic oncology space. In terms of content, the trainee newsletter will seek to summarise the ‘hot-off-the-press’ landmark papers, list … Read More

1 2 3 4 9